Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Quality of Care in French HIV Infected Patients

NCT02898987 · tracked via the Priya Life Science France tracker
Sponsor
DatAids
Phase
Observational
Started
2016-01
Last updated
2026-02-20

Condition(s) studied

HIV

Study summary

The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients seeking care in 15 HIV centers in France in order :

1. to provide and develop a surveillance system to describe clinical practice and temporal changes in the clinical course of HIV and HIV-related co-infections and co-morbidities in France.
2. to assess the factors associated with the clinical, immunological and virological course of HIV infection and HIV-related co-infections and co-morbidities

The specific objectives are as follows

* To continue surveillance of HIV infection in France to describe temporal changes
* To evaluate the efficacy of ART and factors associated with ART efficacy
* To monitor the uptake and outcome of HCV therapy

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status Exclusion Criteria: * Patients under 18 years of age * Patients without written informed consent

Primary outcome measure(s)

  • Proportion of HIV treated patients with HIV plasma viral load < 50 copies/mL — From date of enrollment, through study completion, an average of 6 months

Trial sites (39)

FacilityCityRegionStatus
Hôpital Nord Franche Comté Belfort France Recruiting
CHU Besançon - Hôpital Jean Minjoz Besançon France Recruiting
CHRU Brest Brest France Recruiting
Centre Hospitalier de Brive Brive-la-Gaillarde France Recruiting
CHU Clermont-Ferrand - Hôpital Gabriel-Montpied Clermont-Ferrand France Recruiting
CHIC Créteil France Recruiting
— Faye-l'Abbesse France Recruiting
CHD Vendée La Roche-sur-Yon France Recruiting
Centre Hospitalier de La Rochelle La Rochelle France Recruiting
Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris Le Kremlin-Bicêtre France Recruiting
CHU Limoges Limoges France Recruiting
Hôpital de la Croix-Rousse - Hospices Civils de Lyon Lyon France Recruiting
Hôpital Sainte Marguerite - Assistance Publique des Hôpitaux de Marseille Marseille France Recruiting
IHU - Assistance Publique des Hôpitaux de Marseille Marseille France Recruiting
CHR Metz-Thionville Metz France Recruiting
Hôpital Gui de Chauliac Montpellier France Recruiting
CHU Nancy - Hôpital Brabois Nancy France Recruiting
CHU Nantes - Hôtel-Dieu Nantes France Recruiting
CHU Nice Nice France Recruiting
Centre Hospitalier de Niort Niort France Recruiting
CH Nîmes Nîmes France Recruiting
CHR Orléans Orléans France Recruiting
Groupe Hospitalier Pitié Salpêtrière - Assistance Publique des Hôpitaux de Paris Paris France Recruiting
Hôpital Bichat - Assistance Publique des Hôpitaux de Paris Paris France Recruiting
Hôpital Necker-Pasteur - Assistance Publique des Hôpitaux de Paris Paris France Recruiting
Centre Hospitalier de Cornouaille Quimper France Recruiting
CHU Reims - Hôpital Robert Debré Reims France Recruiting
CHU Rennes - Hôpital Pontchaillou Rennes France Recruiting
CH Rochefort Rochefort France Recruiting
CHU Rouen Rouen France Recruiting
CHU St Etienne - Hôpital Nord Saint-Etienne France Recruiting
CHU Strasbourg - Hôpital Civil Strasbourg France Recruiting
CHU Toulouse - Hôpital Purpan Toulouse France Recruiting
CHU Tourcoing - Hôpital Guy Chatiliez Tourcoing France Recruiting
CH Troyes Troyes France Recruiting
CH Bretagne-Atlantique Vannes France Recruiting
CHIV Villeneuve-Saint-Georges France Recruiting
CHU de Guadeloupe Pointe-à-Pitre Guadeloupe Recruiting
CHU de Martinique Fort-de-France Martinique Recruiting

More DatAids trials in France

Dat'Aids Prevention Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02898987 on ClinicalTrials.gov ↗ ← All trials in France